Matt Might is an active advisor to the newly established Undiagnosed Disease Network Coordinating Center at Harvard University. He is passionate about patient-driven precision medicine, accelerating drug development in rare disease, and bending the cost curve in medical research with computation and social media. He recently co-authored a white paper for the President’s precision medicine initiative.
Might is also the father of the first patient ever discovered with a novel ultra-rare disorder, N-glycanase (NGLY1) deficiency. After the diagnosis, he applied his expertise as a professor in computer science to find more cases through social media, finding the second case in just two months. In parallel, Might launched a collaboration with glycobiologist Dr. Hudson Freeze intended to understand and ultimately treat the disorder.
Outside of medicine, Might is an associate professor in the School of Computing at the University of Utah, where he runs a successful research lab in cybersecurity and scientific computing, conducting research for DARPA, the National Nuclear Security Administration, and the National Science Foundation. Credited with breakthroughs in automated program analysis and machine parsing of language, in 2014, he received a CAREER Award from the National Science Foundation and was named one of six Presidential Scholars at the University of Utah. Might holds a Ph.D. in computer science from Georgia Tech.
